The cryocare TM targeted cryoablation therapy is also called argon-helium knife. It employs the space rocket guidance technology and the oncology theory of modern ultra-low temperature cryotherapy. The refrigerant (argon) can freeze the lesion to -140℃ while the thermal medium (helium) can heat it up to 45℃. This process takes no more than 50s and the combination of argon and helium destroys and kills cancer cells. Because of the destruction of cancer cell, the antigen of cancer cell enters into the blood and boosts the immune system to generate the cellular and humoral immune response, thus improving the immunity.
As the argon-helium ultra-cold knife is a minimally invasive treatment and it can completely eradicate the tumors, it can be applied to the patients including post-surgery recurrent patients, elder people, people in weak condition, people unwilling to undergo surgery, patient with metastasis, cancer patient with aortic surrounding tissues that cannot be removed through surgery, patients with poor therapeutic effect of radiotherapy, chemotherapy and other therapies or patient no longer sensitive to those therapies, patients that suffer from treatment failure. The cryoablation therapy can minimize the tumor burden, quickly relieve pain, greatly improve the therapeutic effect of immune therapy, traditional Chinese medicine, radiotherapy and follow-up care, reduce side effect, effectively extend life span and improve the quality of life.
